Leflunomide in Patients With PTEN-null Advanced Solid Malignancies
Status:
Not yet recruiting
Trial end date:
2026-09-01
Target enrollment:
Participant gender:
Summary
Leflunomide in patients with PTEN-null advanced solid tumors. Objectives are to determine the
safety and tolerability and the MTD of leflunomide in patients with PTEN-null advanced solid
malignancies and to assess preliminary evidence of clinical activity of leflunomide in
patients with PTEN-null advanced solid malignancies.